Literature DB >> 31160390

The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity.

Xaria X Li1, John D Lee1, Claudia Kemper2, Trent M Woodruff3.   

Abstract

Complement activation generates the core effector protein C5a, a potent immune molecule that is linked to multiple inflammatory diseases. Two C5a receptors, C5aR1 (C5aR, CD88) and C5aR2 (C5L2, GPR77), mediate the biological activities of C5a. Although C5aR1 has broadly acknowledged proinflammatory roles, C5aR2 remains at the center of controversy, with existing findings supporting both immune-activating and immune-dampening functions. Recent progress has been made toward resolving these issues. Instead of being a pure recycler and sequester of C5a, C5aR2 is capable of mediating its own set of signaling events and through these events exerting significant immunomodulatory effects not only toward C5aR1 but also other pattern recognition receptors and innate immune systems, such as NLRP3 inflammasomes. This review highlights the existing knowns and unknowns concerning C5aR2 and provides a timely update on recent breakthroughs which are expected to have a substantial impact on future fundamental and translational C5aR2 research.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31160390     DOI: 10.4049/jimmunol.1900371

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  Inflammation in Hypertension.

Authors:  Liang Xiao; David G Harrison
Journal:  Can J Cardiol       Date:  2020-01-24       Impact factor: 5.223

2.  Bothrops lanceolatus snake (Fer-de-lance) venom triggers inflammatory mediators' storm in human blood.

Authors:  Felipe Silva de França; Joel José Megale Gabrili; Laurence Mathieu; François Burgher; Joël Blomet; Denise V Tambourgi
Journal:  Arch Toxicol       Date:  2021-01-04       Impact factor: 5.153

Review 3.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

Review 4.  COVID-19: Complement, Coagulation, and Collateral Damage.

Authors:  Martin W Lo; Claudia Kemper; Trent M Woodruff
Journal:  J Immunol       Date:  2020-07-22       Impact factor: 5.422

5.  Knockout mouse models reveal the contributions of G protein subunits to complement C5a receptor-mediated chemotaxis.

Authors:  Esther van den Bos; Benjamin Ambrosy; Markus Horsthemke; Stefan Walbaum; Anne C Bachg; Nina Wettschureck; Giulio Innamorati; Thomas M Wilkie; Peter J Hanley
Journal:  J Biol Chem       Date:  2020-04-24       Impact factor: 5.157

6.  Pressure Cycling Technology Assisted Mass Spectrometric Quantification of Gingival Tissue Reveals Proteome Dynamics during the Initiation and Progression of Inflammatory Periodontal Disease.

Authors:  Kai Bao; Xiaofei Li; Tetsuhiro Kajikawa; Abe Toshiharu; Nathalie Selevsek; Jonas Grossmann; George Hajishengallis; Nagihan Bostanci
Journal:  Proteomics       Date:  2020-01-15       Impact factor: 3.984

Review 7.  Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets.

Authors:  Andrea J Tenner
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

Review 8.  Sterile inflammation in thoracic transplantation.

Authors:  C Corbin Frye; Amit I Bery; Daniel Kreisel; Hrishikesh S Kulkarni
Journal:  Cell Mol Life Sci       Date:  2020-08-17       Impact factor: 9.261

9.  In Vivo Pharmacodynamic Method to Assess Complement C5a Receptor Antagonist Efficacy.

Authors:  Cedric S Cui; Vinod Kumar; Declan M Gorman; Richard J Clark; John D Lee; Trent M Woodruff
Journal:  ACS Pharmacol Transl Sci       Date:  2021-12-21

10.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.